Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen Idec May Have Seeds For Next-Gen MS Drugs
Investors.com
Monday, April 7, 2014 - 5:08pm
tags:
MS, Biogen Idec, multiple sclerosis, BIIB-061, remylination, Tecfidera
Takeda Showed Disregard in Handling Diabetes Drug, Jury Told
Bloomberg
Monday, April 7, 2014 - 5:07pm
tags:
Takeda, diabetes, Actos
GlaxoSmithKline Faces Bribery Allegations Yet Again, This Time in Iraq
Wall St Cheat Sheet
Monday, April 7, 2014 - 5:04pm
tags:
GSK, Iraq, China, bribery
If Glaxo's CEO wants to be Mr. Clean, he needs to pick up a broom
Fierce Pharma Marketing
Monday, April 7, 2014 - 1:04pm
tags:
GSK, Pharma CEOs, Andrew Witty
Hologic, GE, PositiveID land near $100M in Defense contracts
Mass Device
Monday, April 7, 2014 - 1:00pm
tags:
General Electric, PositiveID, devices, Hologic, defense contracts
Immunomedics reports results from three IMMU-130 phase I trials
Yahoo/Fly on the Wall
Monday, April 7, 2014 - 12:59pm
tags:
Immunomedics, IMMU-130, colorectal cancer
Boehringer Ingelheim's Oral Anticoagulant Gains New Indication
Forbes
Monday, April 7, 2014 - 12:57pm
tags:
Boehringer Ingelheim, anticlotting, Pradaxa, deep venous thrombosis, DVT, pulmonary embolism
FDA Keeps Driving Up Future Cost of Inhalable Insulin
Yahoo/247WallStreet
Monday, April 7, 2014 - 12:56pm
tags:
FDA, inhaled insulin, diabetes, Afrezza, MannKind
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Monday, April 7, 2014 - 12:54pm
tags:
physicians, Sovaldi, Gilead Sciences, hepatitis C
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Forbes
Monday, April 7, 2014 - 12:53pm
tags:
FDA, Novartis, Bexsero, vaccines, breakthrough therapies, meningitis B
Puma drug better than Herceptin in HER2 breast cancers -trial
Reuters
Monday, April 7, 2014 - 10:33am
tags:
Herceptin, Puma Biotechnology, HER2 Inhibitor, breast cancer, neratinib
Biotech's breathless quarter of IPOs brings in $2.1B for R&D
Fierce Biotech
Monday, April 7, 2014 - 10:30am
tags:
biotech, IPOs
This Biotech Market Could Quadruple -- 3 Stocks To Profit
Yahoo/Street Authority
Monday, April 7, 2014 - 10:28am
tags:
vaccines, Merck, Gardasil, Pfizer, Prevnar 13, Novavax, NanoViricides, Inovio
Novartis AG Seeks to Pump More Value into its R&D
Motley Fool
Monday, April 7, 2014 - 10:25am
tags:
Novartis, R&D
FirstWord Lists – The Quarterly: 10 key pharma events that occurred in Q1
First Word Pharma
Monday, April 7, 2014 - 10:24am
tags:
immuno-oncology, Sovaldi, Gilead Sciences, Teva Pharmaceuticals, Copaxone, GSK, Breo Ellipta, Forest Labs, Actavis, M&A, Affordable Care Act, biosimilars, PCSK9 inhibitors
Should Med School Leaders Serve On Pharma Boards?
Forbes
Monday, April 7, 2014 - 10:00am
tags:
Bristol-Myers submits NDAs for Hep C drugs
Seeking Alpha
Monday, April 7, 2014 - 9:57am
tags:
Bristol-Myers Squibb, daclatasvir, asunaprevir, hepatitis C, FDA
PharmAthene Updates Status Of SparVax Anthrax Vaccine Contract
Yahoo/Benzinga
Monday, April 7, 2014 - 9:44am
tags:
PharmAthene, anthrax, vaccines, SparVax
Mallinckrodt to buy Questcor in cash-and-shares deal
Marketwatch
Monday, April 7, 2014 - 8:48am
tags:
Mallinckrodt, Questcor, M&A
Sanofi: Genzyme to Resubmit Lemtrada Application for FDA Review
Yahoo
Monday, April 7, 2014 - 8:47am
tags:
Sanofi, Genzyme, Lemtrada, FDA, MS, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.